• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ludwig Kappos - Articles and news items

Genzyme logo

European Commission approves Genzyme’s once-daily, oral multiple sclerosis treatment Aubagio® (teriflunomide)

Industry news, News / 30 August 2013 / Sanofi

Sanofi and its subsidiary Genzyme announced that the European Commission has granted marketing authorization for Aubagio® (teriflunomide)…


Genzyme presents second Phase III study of once-daily oral AUBAGIO® (teriflunomide) confirming significant impact on disability

Industry news, News / 12 October 2012 / Sanofi

Sanofi and Genzyme announced that key data from the TOWER trial were presented at the 28th Congress of the ECTRIMS…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +